Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy - Top-Institutions - MDSpire

Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy

  • By

  • Laura Patrussi

  • Chenran Zhang

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Oncology
    • Medicine

  • #4

    Ludwig-Maximilians-Universität München
    Ludwig-Maximilians-Universität München

    Munich, Bavaria

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy

  • by Laura Patrussi, Chenran Zhang

  • June 11, 2026

Related Content

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study

MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment

The unheard pain: why patient-related barriers remain the weakest link in cancer pain management